Endurant Capital Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-20,754
| Closed | -$336K | – | 56 |
|
|
2023
Q2 | $336K | Sell |
20,754
-36,289
| -64% | -$588K | 0.29% | 30 |
|
|
2023
Q1 | $950K | Sell |
57,043
-375,992
| -87% | -$6.26M | 0.49% | 39 |
|
|
2022
Q4 | $4.07M | Buy |
+433,035
| New | +$4.07M | 1.65% | 17 |
|
|
2019
Q2 | – | Sell |
-178,448
| Closed | -$1.77M | – | 78 |
|
|
2019
Q1 | $1.77M | Buy |
178,448
+124,982
| +234% | +$1.24M | 0.7% | 39 |
|
|
2018
Q4 | $409K | Sell |
53,466
-18,511
| -26% | -$142K | 0.22% | 47 |
|
|
2018
Q3 | $1.25M | Buy |
71,977
+11,478
| +19% | +$200K | 0.56% | 41 |
|
|
2018
Q2 | $574K | Sell |
60,499
-58,601
| -49% | -$556K | 0.25% | 55 |
|
|
2018
Q1 | $520K | Buy |
+119,100
| New | +$520K | 0.19% | 65 |
|